Stocks and Investing Stocks and Investing
Wed, April 17, 2024

Colin Bristow Maintained (AMGN) at Hold with Decreased Target to $284 on, Apr 17th, 2024


Published on 2024-10-28 10:25:21 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $314 to $284 on, Apr 17th, 2024.

Colin has made no other calls on AMGN in the last 4 months.



There are 8 other peers that have a rating on AMGN. Out of the 8 peers that are also analyzing AMGN, 2 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gary Nachman of "Raymond James" Initiated at Hold on, Thursday, March 28th, 2024
  • Terence Flynn of "Morgan Stanley" Maintained at Hold with Decreased Target to $278 on, Wednesday, February 7th, 2024


These are the ratings of the 6 analyists that currently disagree with Colin


  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $320 on, Friday, April 12th, 2024
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $329 on, Wednesday, April 3rd, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $350 on, Thursday, February 8th, 2024
  • Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $350 on, Thursday, February 1st, 2024
  • Narumi Nakagiri of "Daiwa Capital" Upgraded from Hold to Strong Buy and Held Target at $320 on, Thursday, December 21st, 2023
  • Evan David Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $326 on, Tuesday, December 19th, 2023
Contributing Sources